Cytosine Methyltransferases as Tumor Markers

  • Pavlopoulou A
  • Kossida S
4Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Changes in DNA methylation patterns is a prominent characteristic of human tumors. Tumor cells display reduced levels of genomic DNA methylation and site-specific CpG island hypermethylation. Methylation of CpG dinucleotides is catalyzed by the enzyme family of DNA methyltransferases (DNMTs). In this review, the role of DNA methylation and DNMTs as key determinants of carcinogenesis is further elucidated. The chromatin modifying proteins that are known to interact with DNMTs are also described. Finally, the role of DNMTs as potential therapeutic targets is addressed. © 2010 Bentham Science Publishers Ltd.

Cite

CITATION STYLE

APA

Pavlopoulou, A., & Kossida, S. (2010). Cytosine Methyltransferases as Tumor Markers. Current Genomics, 11(8), 568–577. https://doi.org/10.2174/138920210793360916

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free